1. Home
  2. HCSG vs SNDX Comparison

HCSG vs SNDX Comparison

Compare HCSG & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCSG
  • SNDX
  • Stock Information
  • Founded
  • HCSG 1976
  • SNDX 2005
  • Country
  • HCSG United States
  • SNDX United States
  • Employees
  • HCSG N/A
  • SNDX N/A
  • Industry
  • HCSG Assisted Living Services
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCSG Health Care
  • SNDX Health Care
  • Exchange
  • HCSG Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • HCSG 1.1B
  • SNDX 1.1B
  • IPO Year
  • HCSG N/A
  • SNDX 2016
  • Fundamental
  • Price
  • HCSG $13.12
  • SNDX $9.34
  • Analyst Decision
  • HCSG Buy
  • SNDX Strong Buy
  • Analyst Count
  • HCSG 5
  • SNDX 11
  • Target Price
  • HCSG $14.80
  • SNDX $34.00
  • AVG Volume (30 Days)
  • HCSG 772.4K
  • SNDX 2.0M
  • Earning Date
  • HCSG 07-23-2025
  • SNDX 07-31-2025
  • Dividend Yield
  • HCSG N/A
  • SNDX N/A
  • EPS Growth
  • HCSG N/A
  • SNDX N/A
  • EPS
  • HCSG 0.55
  • SNDX N/A
  • Revenue
  • HCSG $1,739,911,000.00
  • SNDX $43,722,000.00
  • Revenue This Year
  • HCSG $7.54
  • SNDX $431.08
  • Revenue Next Year
  • HCSG $4.55
  • SNDX $105.38
  • P/E Ratio
  • HCSG $23.71
  • SNDX N/A
  • Revenue Growth
  • HCSG 3.71
  • SNDX N/A
  • 52 Week Low
  • HCSG $9.13
  • SNDX $8.58
  • 52 Week High
  • HCSG $15.73
  • SNDX $25.07
  • Technical
  • Relative Strength Index (RSI)
  • HCSG 31.22
  • SNDX 51.90
  • Support Level
  • HCSG $12.75
  • SNDX $8.59
  • Resistance Level
  • HCSG $15.19
  • SNDX $10.01
  • Average True Range (ATR)
  • HCSG 0.54
  • SNDX 0.51
  • MACD
  • HCSG -0.24
  • SNDX 0.15
  • Stochastic Oscillator
  • HCSG 12.42
  • SNDX 87.46

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: